These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6678871)

  • 1. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology Group.
    Knight WA; Fabian C; Costanzi JJ; Jones SE; Coltman CA
    Invest New Drugs; 1983; 1(3):235-7. PubMed ID: 6678871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology Group.
    Knight WA; O'Bryan RM; Samal B; Costanzi JJ
    Invest New Drugs; 1984; 2(1):71-3. PubMed ID: 6469501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of methyl-GAG (methylglyoxal-bis[guanylhydrazone]) in patients with advanced malignant lymphoma.
    Warrell RP; Lee BJ; Kempin SJ; Lacher MJ; Straus DJ; Young CW
    Blood; 1981 Jun; 57(6):1011-4. PubMed ID: 7013854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
    Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
    Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
    Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
    [No Abstract]   [Full Text] [Related]  

  • 6. Mitoxantrone hydrochloride (NSC-310739) in lymphoma. A Southwest Oncology Group study.
    Coltman CA; McDaniel TM; Balcerzak SP; Morrison FS; Von Hoff DD
    Invest New Drugs; 1983; 1(1):65-70. PubMed ID: 6678857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
    Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF
    Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
    Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
    Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I-II trial of methyl-GAG: a Southwest Oncology Group Pilot Study.
    Knight WA; Livingston RB; Fabian C; Costanzi J
    Cancer Treat Rep; 1979; 63(11-12):1933-7. PubMed ID: 526927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone, cisplatin, and methyl-glyoxal bis-guanylhydrazone chemotherapy for refractory malignant lymphoma: a Southwest Oncology Group phase II trial.
    Dana B; Dahlberg S; Schnitzer B; Kjeldsberg CR; Jones SE; Carden J; Mundis R; Tranum B
    Invest New Drugs; 1989 Jul; 7(2-3):247-50. PubMed ID: 2793382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lung.
    Killen JY; Mitchell EP; Hoth DF; Willis LL; Gullo JJ; Smith FP; Schein PS; Woolley PV
    Cancer; 1982 Oct; 50(7):1258-61. PubMed ID: 7104970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of methyl-glyoxal bis-guanylhydrazone (NSC 3296) in advanced ovarian cancer.
    Vogl SE; Pagano M; Horton J
    Am J Clin Oncol; 1984 Dec; 7(6):733-6. PubMed ID: 6528867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-GAG in patients with malignant neoplasms: a phase I re-evaluation.
    Hart RD; Ohnuma T; Holland JF; Bruckner H
    Cancer Treat Rep; 1982 Jan; 66(1):65-71. PubMed ID: 7053268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trials of methylglyoxal-bis (guanylhydrazone).
    Kelsen DP; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla RJ; Casper E; Young CW
    Am J Clin Oncol; 1982 Apr; 5(2):221-5. PubMed ID: 7046414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I--II trial of methyl-GAG in the treatment of patients with metastatic renal adenocarcinoma.
    Todd RF; Garnick MB; Canellos GP; Richie JP; Gittes RF; Mayer RJ; Skarin AT
    Cancer Treat Rep; 1981; 65(1-2):17-20. PubMed ID: 7226167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
    Knight WA; Drelichman A; Fabian C; Bukowski RM
    Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study.
    Jones SE; Tucker WG; Haut A; Tranum BL; Vaughn C; Chase EM; Durie BG
    Cancer Treat Rep; 1977 Dec; 61(9):1617-21. PubMed ID: 340032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for patients with relapsed malignant lymphoma using methyl-GAG and teniposide (VM-26).
    Warrell RP; Straus DJ; Young CW
    Cancer Treat Rep; 1982 May; 66(5):1121-5. PubMed ID: 7044533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of methyl-GAG in advanced renal cancer.
    Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
    Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
    [No Abstract]   [Full Text] [Related]  

  • 20. Cisplatin, VP-16-213 and MGBG (methylglyoxal bis guanylhydrazone) combination chemotherapy in refractory lymphoma, a phase II study.
    Dabich L; Liepman MK
    Invest New Drugs; 1988 Sep; 6(3):231-7. PubMed ID: 3192389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.